Drug Flashcards
What are presynaptic events, and how do drugs affect them to produce their effects?
Key Findings:
• Presynaptic Events (突触前事件):
• These are steps that occur in the presynaptic neuron before neurotransmitter release, including:
• Synthesis of neurotransmitters
• Storage in vesicles
• Vesicle docking and fusion
• Release into synaptic cleft upon arrival of an action potential
• How Drugs Affect Presynaptic Events:
• Altering NT Synthesis: Drugs can increase or block the production of neurotransmitters.
• Example: L-DOPA boosts dopamine production.
• Blocking Vesicle Transport or Release:
• Example: Reserpine interferes with vesicle storage of monoamines.
• Enhancing NT Release:
• Example: Amphetamines cause excessive dopamine release.
• Blocking Autoreceptors (which normally reduce NT release):
• Increases NT output by removing feedback inhibition.
• Modulating Presynaptic Calcium Channels:
• Drugs can enhance or inhibit calcium influx, which directly affects vesicle fusion and NT release.
Key Takeaway:
• Drugs can modify presynaptic events by altering neurotransmitter synthesis, storage, and release—ultimately changing how much and how often neurotransmitters reach the postsynaptic cell, producing therapeutic or psychoactive effects.
How do specific drugs affect neurotransmitter release by targeting presynaptic mechanisms?
Key Findings:
• Blocking Na⁺ Channels → Prevent Action Potentials
• Tetrodotoxin (TTX):
• Found in pufferfish.
• Blocks voltage-gated Na⁺ channels, preventing action potential propagation.
• Result: No depolarization, so no NT release.
• Novocain (局部麻醉剂):
• Blocks Na⁺ channels locally.
• Prevents sensory neuron signals from firing, leading to localized numbness.
• Blocking Ca²⁺ Entry → Prevent Vesicle Fusion & NT Release
• Calcium channels are essential for triggering vesicle fusion and neurotransmitter release.
• Blocking these channels stops NT from being released even if an AP arrives.
• Botox (Botulinum Toxin):
• Blocks vesicle fusion machinery (SNARE proteins) in acetylcholine neurons.
• Prevents ACh release at neuromuscular junctions.
• Result: Paralysis of muscles (used cosmetically and medically).
• Tetanus Toxin:
• Released by Clostridium tetani (破伤风菌).
• Blocks inhibitory neurotransmitter (e.g., GABA) release from spinal interneurons.
• Result: Uncontrolled motor neuron firing → severe muscle spasms.
Key Takeaway:
• Drugs and toxins like TTX, Novocain, Botox, and tetanus interfere with neurotransmitter release by blocking Na⁺/Ca²⁺ channels or vesicle fusion, leading to paralysis, numbness, or excessive motor activity depending on the target.
What are autoreceptors, and how do drugs like caffeine affect neurotransmitter release through them?
Key Findings:
• Autoreceptors (自体受体):
• Located on the presynaptic neuron.
• Function as a feedback mechanism—they monitor and regulate how much neurotransmitter is being released.
• When activated by their own neurotransmitter, they typically inhibit further release to maintain balance.
• Stimulation of Autoreceptors → Inhibition of Release
• Example: When serotonin binds to its own autoreceptors, the presynaptic neuron reduces further serotonin release.
• This is a self-regulating mechanism to prevent overstimulation.
• Blocking Autoreceptors → Increased NT Release
• If a drug blocks these autoreceptors, it removes the inhibition, causing the presynaptic neuron to release more neurotransmitter.
• This can enhance signaling, especially with repeated stimulation.
• Caffeine:
• Acts as a stimulant by blocking adenosine receptors, which normally inhibit neurotransmitter release.
• By blocking adenosine, caffeine leads to increased dopamine and norepinephrine release, promoting alertness and arousal.
• It does not act on autoreceptors directly, but removes inhibitory tone from another regulatory system.
Key Takeaway:
• Autoreceptors help regulate neurotransmitter release via feedback inhibition. Blocking them (or similar inhibitory systems like adenosine with caffeine) leads to increased NT release and greater synaptic activity.
What is neurotransmitter clearance, and how do drugs affect it through transporter blockade and degradation enzymes like acetylcholinesterase?
Key Findings:
• Clearance (清除作用):
• After neurotransmitters are released into the synaptic cleft, they must be cleared to stop signaling and reset the synapse.
• Two main clearance mechanisms:
1. Reuptake by transporters (转运体回收)
2. Enzymatic degradation (酶解降解)
⸻
• Block Transporters → Prolong NT Action • Transporters on the presynaptic terminal reabsorb neurotransmitters for reuse or breakdown. • Blocking these transporters leads to more NT in the synaptic cleft, enhancing its effect. • Examples: • SSRIs (选择性5-羟色胺再摄取抑制剂): Block serotonin reuptake → treat depression. • Cocaine and amphetamines: Block dopamine reuptake → increase euphoria and arousal.
⸻
• Enzymatic Degradation → Inactivate NT • Enzymes in the synapse break down neurotransmitters, stopping their action. • Acetylcholinesterase (AChE): • Breaks down acetylcholine (ACh) in the synaptic cleft into acetate + choline. • This is crucial for ending muscle contraction signals at neuromuscular junctions. • AChE inhibitors (e.g., used in Alzheimer’s treatment) increase ACh availability to improve cognition.
Key Takeaway:
• Clearance of neurotransmitters occurs via reuptake or enzymatic degradation. Drugs can block transporters or enzymes like acetylcholinesterase to prolong or intensify neurotransmitter effects.
What are postsynaptic events, and how can drugs in the central nervous system (CNS) affect these cellular processes?
Key Findings:
• Postsynaptic Events (突触后事件):
• Begin when neurotransmitters bind to receptors on the postsynaptic membrane.
• This triggers changes such as:
• Opening ion channels → alters membrane potential (e.g., EPSPs or IPSPs)
• Activating second messengers → triggers longer-term intracellular effects
• Gene expression changes → affects receptor density, protein production
⸻
• How CNS Drugs Affect Postsynaptic Events: • Mimic neurotransmitters (agonists) → activate postsynaptic receptors directly. • Block receptors (antagonists) → prevent neurotransmitter binding and action. • Modulate receptor sensitivity → enhance or reduce receptor response to NTs. • Act on intracellular signaling pathways: • Affect second messengers like cAMP or calcium. • Alter gene transcription and protein synthesis, changing neuronal structure/function.
⸻
• Cellular-Level Effects: • Changes in receptor number (upregulation/downregulation) • Synaptic plasticity (long-term potentiation or depression) • Altered excitability of the neuron • In long-term use, CNS drugs may lead to neural circuit remodeling or tolerance.
Key Takeaway:
• Postsynaptic events involve receptor activation, ion flow, and intracellular signaling. CNS drugs can enhance or inhibit these processes, producing short-term effects (like excitation/inhibition) and long-term changes (like plasticity or tolerance).
How do agonists and antagonists affect neurotransmitter receptors?
Key Findings:
• Agonists (激动剂):
• Mimic the natural neurotransmitter by binding to its receptor and activating it.
• Can produce the same or even a stronger effect than the endogenous transmitter.
• Example:
• Morphine → Agonist at opioid receptors → Produces pain relief and euphoria.
• Nicotine → Agonist at nicotinic acetylcholine receptors → Stimulates alertness and attention.
• Antagonists (拮抗剂):
• Bind to the receptor but do not activate it.
• Instead, they block the natural neurotransmitter from binding, reducing or preventing receptor activation.
• Example:
• Haloperidol → Dopamine antagonist → Used to treat schizophrenia by reducing dopamine signaling.
• Curare → ACh receptor antagonist → Causes paralysis by blocking neuromuscular transmission.
Key Takeaway:
• Agonists activate neurotransmitter receptors to enhance signaling, while antagonists block receptors to reduce or prevent neurotransmitter effects. Both types of drugs are crucial in modulating brain function for therapeutic or psychoactive outcomes.
What intracellular processes do drugs affect, and how does lithium chloride work?
Key Findings:
• Intracellular Processes (细胞内过程):
• After a neurotransmitter or drug binds to a postsynaptic receptor, it can activate intracellular signaling cascades, especially through metabotropic receptors (G-protein-coupled).
• These processes include:
• Second messengers (e.g., cAMP, IP3) → amplify the signal inside the cell.
• Activation of protein kinases → modify proteins to alter cell function.
• Changes in gene expression → affect long-term neuronal structure and behavior.
• Regulation of receptor sensitivity and synaptic plasticity.
⸻
• Lithium Chloride (LiCl): • A mood stabilizer, commonly used to treat bipolar disorder. • It works by modulating intracellular signaling, especially in neurons involved in mood regulation. • Mechanisms include: • Inhibiting second messenger pathways (e.g., inositol phosphate system). • Altering gene expression and neuroplasticity over time. • Stabilizing neuronal activity to reduce extreme mood swings.
Key Takeaway:
• Drugs can influence intracellular processes like second messenger signaling and gene expression. Lithium chloride acts within neurons to stabilize mood by modulating these internal pathways, especially in bipolar disorder.
What are DREADDs, and how are they used in neuroscience research?
Key Findings:
• What Are DREADDs?
• DREADDs are genetically engineered receptors that do not respond to natural neurotransmitters, but can be activated by synthetic (designer) drugs.
• The most commonly used designer drug is CNO (clozapine-N-oxide).
• Purpose:
• Used to selectively control the activity of specific neurons in live animals.
• Researchers insert DREADDs into targeted brain regions via gene delivery (e.g., viral vectors).
• Administering CNO will activate or inhibit only the neurons with DREADDs, allowing precise, reversible control.
• Types of DREADDs:
• Excitatory DREADDs → Activate neurons when CNO is applied.
• Inhibitory DREADDs → Silence neurons when activated.
• Applications:
• Studying specific circuits in behavior, emotion, addiction, memory, etc.
• Offers non-invasive, reversible, and cell-type-specific manipulation.
Key Takeaway:
• DREADDs are engineered receptors activated only by synthetic drugs, enabling researchers to precisely and reversibly control specific neurons and study their roles in brain function and behavior.
How are optogenetics and DREADDs similar, and how do they differ in neuroscience research?
Key Findings:
• Shared Purpose:
• Both optogenetics and DREADDs are powerful techniques used to precisely control specific neurons in the brain.
• Allow researchers to study how specific circuits contribute to behavior, emotion, learning, and disease.
⸻
• DREADDs (化学遗传学工具): • Slower, long-lasting control (minutes to hours). • Uses engineered receptors activated by designer drugs (e.g., CNO). • Non-invasive once delivered—drug can be administered systemically. • Ideal for studying longer-term behavioral effects. • Optogenetics (光遗传学工具): • Fast, precise control (millisecond resolution). • Uses light-sensitive ion channels (e.g., channelrhodopsin) introduced into neurons. • Requires surgical implantation of fiber optics to shine light on the target brain area. • Ideal for studying rapid neural dynamics and timing in real time.
⸻
Key Takeaway:
• DREADDs and optogenetics both allow targeted control of neurons, but DREADDs use designer drugs for slow, sustained modulation, while optogenetics uses light for fast, precise activation or inhibition.
What are key neuroscience breakthroughs in treating mental disorders over the past 70 years?
Key Findings:
• Neuroscience has revealed that mental disorders arise from brain dysfunction, not just behavior.
• This led to the development of targeted drug treatments, including:
• First-generation antipsychotics (e.g., chlorpromazine) → treat positive symptoms of schizophrenia, like hallucinations.
• Second-generation antipsychotics → also address negative symptoms (e.g., social withdrawal), with fewer motor side effects.
• Antidepressants (e.g., SSRIs) and mood stabilizers (e.g., lithium) for depression and bipolar disorder.
• These advances shifted psychiatry toward a biological model and opened the door to modern brain-based therapies.
Key Takeaway:
• Neuroscience has enabled drug-based treatments for mental illness, from first- and second-generation antipsychotics to antidepressants—redefining mental health as a brain-based condition.
What are antidepressants, and how do they work?
Key Findings:
• Antidepressants (抗抑郁药) are drugs used to treat depression, as well as anxiety disorders, OCD, and PTSD.
• They work by increasing the availability of neurotransmitters (especially serotonin, norepinephrine, and dopamine) in the brain to improve mood and emotional regulation.
⸻
• Major Types of Antidepressants: • SSRIs (选择性5-羟色胺再摄取抑制剂) • Block reuptake of serotonin → more remains in the synapse. • Example: Prozac, Zoloft • SNRIs (5-羟色胺-去甲肾上腺素再摄取抑制剂) • Block reuptake of serotonin and norepinephrine. • MAOIs (单胺氧化酶抑制剂) • Inhibit the enzyme that breaks down monoamines → increases all monoamines. • Tricyclic Antidepressants (三环类抗抑郁药) • Older drugs that block reuptake of several NTs, but with more side effects.
⸻
Key Takeaway:
• Antidepressants treat mood disorders by boosting key neurotransmitters in the brain, especially serotonin. Different classes target different mechanisms to restore emotional balance.
What are tricyclic antidepressants, SSRIs, and SNRIs, and how do they differ?
Key Findings:
• Tricyclic Antidepressants (TCAs, 三环类抗抑郁药)
• Block reuptake of serotonin and norepinephrine, increasing both in the synapse.
• Also affect other receptors (e.g., histamine, acetylcholine), causing more side effects.
• Examples: Amitriptyline, Imipramine
• Side effects: sedation, dry mouth, weight gain, heart arrhythmias.
• Selective Serotonin Reuptake Inhibitors (SSRIs, 选择性5-羟色胺再摄取抑制剂)
• Block only serotonin reuptake, increasing serotonin levels in a more targeted way.
• Fewer side effects, better tolerated.
• Examples: Prozac (fluoxetine), Zoloft (sertraline)
• Side effects: insomnia, nausea, sexual dysfunction.
• Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs, 5-羟色胺–去甲肾上腺素再摄取抑制剂)
• Block reuptake of both serotonin and norepinephrine, similar to TCAs but more selective.
• Designed to provide dual-action relief for depression and anxiety with fewer side effects than TCAs.
• Examples: Effexor (venlafaxine), Cymbalta (duloxetine)
Key Takeaway:
• TCAs, SSRIs, and SNRIs all increase monoamine levels but differ in selectivity and side effects. SSRIs are most selective (serotonin only), SNRIs target two systems with fewer side effects than TCAs, which are broader but less tolerable.
What are depressants, and how do anxiolytics, barbiturates, and benzodiazepines like alprazolam and lorazepam work?
Key Findings:
• Depressants (抑制剂类药物):
• Drugs that reduce nervous system activity, producing calming, anti-anxiety, or sedative effects.
• Used to treat anxiety, insomnia, seizures, and sometimes for anesthesia.
⸻
• Anxiolytics (抗焦虑药): • General term for drugs that reduce anxiety. • Most common type: Benzodiazepines. • Barbiturates (巴比妥类): • Older class of depressants. • Enhance GABA-A receptor activity → Increase inhibition in the brain. • Risky: Narrow therapeutic window → high overdose and dependence potential. • Largely replaced by safer benzodiazepines. • Benzodiazepine Agonists (苯二氮卓激动剂): • Bind to GABA-A receptors, enhancing GABA’s inhibitory effect. • Safer than barbiturates, widely used to treat anxiety, panic, and insomnia. • Do not directly activate the receptor but increase the effect of GABA. • Examples: • Alprazolam (Xanax) → fast-acting anti-anxiety med. • Lorazepam (Ativan) → used for anxiety, seizures, and sedation.
Key Takeaway:
• Depressants like benzodiazepines and barbiturates reduce brain activity by enhancing GABA signaling. Benzodiazepines like alprazolam and lorazepam are widely used anxiolytics with lower overdose risk than barbiturates.
How do GABA receptors function, and what roles do orphan receptors, allopregnanolone, and neurosteroids play?
Key Findings:
• GABA-A Receptors (γ-氨基丁酸A受体):
• Ionotropic receptors that allow Cl⁻ (chloride) ions into the neuron → hyperpolarization (makes neuron less likely to fire).
• Main target of depressants like benzodiazepines and barbiturates.
• Receptor Modulation:
• Benzodiazepines bind to a modulatory site on GABA-A receptors → enhance GABA’s inhibitory effect (more Cl⁻ enters).
• They don’t open the channel alone—GABA must be present.
• Barbiturates can both enhance GABA and directly open the channel at high doses, making overdose more likely.
⸻
• Orphan Receptors (孤儿受体): • Receptors with no known endogenous ligand (natural brain chemical that binds to them). • GABA-A receptor subtypes were once considered orphans until ligands like neurosteroids were discovered. • Neurosteroids (神经类固醇): • Naturally produced in the brain, derived from steroid hormones. • Modulate GABA-A receptor activity by binding to unique sites. • Can enhance GABAergic inhibition, producing anxiolytic and calming effects. • Allopregnanolone (别孕烯醇酮): • A type of neurosteroid. • Potent positive modulator of GABA-A receptors. • Linked to stress regulation, mood, and postpartum depression (new drugs like brexanolone mimic this action).
Key Takeaway:
• GABA-A receptors inhibit neural activity via Cl⁻ influx. Benzodiazepines, neurosteroids (like allopregnanolone), and other modulators enhance GABA’s effects. Orphan receptors are those with unknown ligands—some were later found to respond to neurosteroids.
What are opiates, and what do we need to know about opium, morphine, heroin, and fentanyl?
Key Findings:
• Opiates (鸦片类药物):
• Drugs derived from opium poppy (罂粟) or synthetically made to mimic endogenous opioid peptides.
• Bind to opioid receptors in the brain and spinal cord, especially in pain and reward circuits.
• Key Types: • Opium (鸦片): • Natural extract from poppy. Contains morphine and codeine. • Morphine (吗啡): • A potent analgesic (镇痛药). Used medically to relieve severe pain. • Heroin (海洛因): • Chemically modified from morphine. • Crosses the blood-brain barrier quickly, creating intense euphoria. • Highly addictive and illegal in most places. • Fentanyl (芬太尼) (30-40 times stronger than heroin): • Synthetic opioid. Up to 50–100 times more potent than morphine. • Small dosage = high overdose risk. • Accidental fentanyl exposure is a major cause of overdose deaths, often mixed into heroin or counterfeit pills unknowingly. • Effects: • Pain relief, euphoria, sedation • Long-term use leads to tolerance, dependence, and withdrawal • Overdose causes respiratory depression → death
Key Takeaway:
• Opiates like morphine, heroin, and fentanyl are powerful painkillers but carry high risk for addiction and overdose—especially with potent synthetic opioids like fentanyl.
What are opioid receptors, what is the role of the periaqueductal gray (PAG), and what are endogenous opioids?
Key Findings:
• Opioid Receptors (阿片受体):
• G-protein-coupled receptors found throughout the brain, spinal cord, and digestive system.
• Three main subtypes:
• Mu (μ) → pain relief, euphoria, respiratory suppression.
• Delta (δ) → mood regulation, pain modulation.
• Kappa (κ) → pain relief, dysphoria, hallucinations.
• Activated by both natural (e.g., morphine) and endogenous opioids.
• Endogenous Opioids (内源性阿片肽): • Naturally produced peptides in the body that bind to opioid receptors. • Include: • Enkephalins (脑啡肽) • Endorphins (内啡肽) • Dynorphins (强啡肽) • Involved in pain suppression, stress response, reward, and mood. • Periaqueductal Gray (PAG, 导水管周围灰质): • A region in the midbrain that plays a central role in pain modulation. • Rich in opioid receptors. • Activating PAG (e.g., via opioids or electrical stimulation) produces strong analgesic effects by inhibiting pain signals at the spinal level.
Key Takeaway:
• Opioid receptors mediate pain relief and reward by responding to both drugs and endogenous opioids like endorphins. The periaqueductal gray is a key brain area where opioid action suppresses pain perception.
What are the main types of opioid receptors, what do opioid antagonists do, and how does naltrexone work?
Key Findings:
• Three Main Opioid Receptors
• All are metabotropic receptors (G-protein-coupled).
• Mu (μ) receptor: Responsible for pain relief, euphoria, respiratory depression.
• Delta (δ) receptor: Involved in mood regulation and some pain modulation.
• Kappa (κ) receptor: Produces pain relief but can also cause dysphoria and hallucinations.
• Opioid Antagonists (阿片拮抗剂)
• Bind to opioid receptors but do not activate them.
• Instead, they block the effects of opioids, including both drugs (like heroin) and endogenous peptides.
• Used to treat overdose and dependence.
• Naltrexone
• A long-lasting opioid receptor antagonist.
• Blocks all three receptor types, especially mu receptors.
• Used to:
• Treat opioid addiction by preventing drug-induced euphoria
• Help maintain abstinence
• Sometimes also used for alcohol dependence
Key Takeaway:
• Opioids act on three metabotropic receptors: mu, delta, and kappa. Antagonists like naltrexone block these receptors to prevent the effects of opioids, making them useful for treating addiction and overdose.
What is cannabis, and what are the functions of its active ingredients THC and CBD?
Key Findings:
• Cannabis (大麻)
• A psychoactive plant used for recreational, medicinal, and cultural purposes.
• Acts on the endocannabinoid system, which regulates mood, appetite, pain, and memory.
• Main Active Ingredients
• Δ⁹-Tetrahydrocannabinol (THC)
• Primary psychoactive component.
• Binds to CB1 receptors in the brain.
• Produces effects like euphoria, relaxation, altered perception, and impaired memory.
• Cannabidiol (CBD)
• Non-psychoactive compound.
• Interacts with multiple receptor systems, including CB1 and serotonin receptors, but does not cause a high.
• Known for anti-anxiety, anti-inflammatory, and seizure-reducing properties.
• Often used in medical cannabis.
Key Takeaway:
• Cannabis contains THC, which causes psychoactive effects, and CBD, which is non-intoxicating and has therapeutic benefits. Both act on the brain’s cannabinoid system but with different effects.
What are CB1 and CB2 receptors, and how do they differ in location and function?
Key Findings:
• CB1 Receptors
• Found mainly in the central nervous system—especially in the cortex, hippocampus, basal ganglia, and cerebellum.
• Responsible for the psychoactive effects of THC.
• Involved in mood regulation, memory, appetite, pain sensation, and motor control.
• THC is a partial agonist at CB1 receptors.
• CB2 Receptors
• Found mostly in the immune system and peripheral tissues (e.g., spleen, white blood cells).
• Involved in modulating inflammation and immune responses.
• Less associated with psychoactive effects.
• Targeted more often for medical or therapeutic uses (e.g., autoimmune diseases, chronic pain).
Key Takeaway:
• CB1 receptors are mainly in the brain and mediate THC’s psychoactive effects, while CB2 receptors are found in immune cells and are involved in inflammation and immune regulation.
What are stimulants, and how do nicotine and cocaine affect the nervous system?
Key Findings:
• Stimulants (兴奋剂)
• Drugs that increase activity in the central nervous system.
• Enhance alertness, arousal, attention, and often cause euphoria.
• Act by increasing neurotransmitter levels, especially dopamine, norepinephrine, and acetylcholine.
• Nicotine (尼古丁) • Found in tobacco. • Agonist at nicotinic acetylcholine receptors (nAChRs). • Increases dopamine release, especially in reward circuits. • Causes mild stimulation, increased focus, and is highly addictive. • Chronic use → tolerance, dependence, and withdrawal. • Cocaine (可卡因) • Blocks reuptake of dopamine, norepinephrine, and serotonin. • Leads to a strong buildup of these neurotransmitters in the synaptic cleft. • Causes intense euphoria, energy, and confidence, followed by a crash. • Highly addictive, with strong risk for cardiac issues and neurotoxicity.
Key Takeaway:
• Stimulants like nicotine and cocaine increase nervous system activity by boosting neurotransmitter levels. Nicotine acts on acetylcholine receptors, while cocaine blocks reuptake of dopamine and other monoamines, leading to powerful and addictive effects.
What are tolerance and sensitization to cocaine, and what does dual dependence mean?
Key Findings:
• Tolerance to Cocaine (耐受性)
• With repeated use, the body becomes less responsive to some of cocaine’s effects.
• Especially seen in euphoric or mood-related effects.
• Leads users to increase the dose to chase the same high.
• Sensitization to Cocaine (敏化作用)
• In contrast, some effects—especially motor stimulation, anxiety, or craving—can become more intense over time, even with lower doses.
• Sensitization may persist even after drug use stops, increasing the risk of relapse.
• Dual Dependence (双重依赖)
• Occurs when someone becomes dependent on more than one drug, often because the drugs are used together to balance or amplify effects.
• Example: Cocaine and heroin (speedball)
• Cocaine provides stimulation; heroin calms the crash.
• This combination is especially dangerous and increases the risk of overdose.
Key Takeaway:
• Cocaine can lead to both tolerance (reduced euphoric response) and sensitization (increased craving or motor effects). Dual dependence involves addiction to two drugs, often used together to manage or intensify effects.
How can a person become tolerant and sensitized to cocaine at the same time?
Key Findings:
• Different effects of a drug involve different brain systems.
• Cocaine affects multiple neurotransmitters and brain regions (e.g., reward, motor, stress systems).
• Tolerance and sensitization can develop in parallel but in different circuits.
• Tolerance
• Happens when repeated use leads to reduced sensitivity to certain effects, like euphoria.
• This is due to dopamine receptor downregulation or homeostatic adaptation in reward circuits.
• Sensitization
• Happens when other effects (e.g., motor stimulation, craving, or anxiety) become stronger over time.
• Involves changes in other pathways, like the mesolimbic dopamine system or amygdala.
• Sensitization is especially linked to cue-triggered craving and relapse risk.
Key Takeaway:
• A person can be tolerant to cocaine’s euphoric effects while sensitized to its craving or behavioral effects because different neural circuits adapt in opposite ways to repeated drug exposure.
How can tolerance and sensitization happen at the same time—are different brain regions involved?
Tolerance
• Mainly involves the mesocorticolimbic dopamine system, especially:
• Nucleus accumbens
• Prefrontal cortex
• With repeated cocaine use, these areas reduce dopamine receptor sensitivity or decrease dopamine release, leading to weakened euphoria over time.
• Sensitization
• More strongly associated with:
• Ventral tegmental area (VTA)
• Amygdala
• Striatum
• These areas become more reactive to drug cues or drug-related stimuli, increasing motivation, craving, and drug-seeking behavior.
• Even when the “high” weakens, the urge and behavioral drive intensify.
Key Takeaway:
• Tolerance and sensitization occur in different brain circuits—reward-related areas develop tolerance to the pleasurable effects, while cue and habit-related areas become sensitized, heightening craving and relapse risk.
How can a single drug like cocaine cause both tolerance and sensitization?
Key Findings:
• One drug, multiple effects
• Cocaine affects many neurotransmitters and brain regions.
• Each effect (e.g., euphoria, craving, movement, stress) is linked to different circuits.
• Tolerance develops
• In reward systems like the nucleus accumbens → repeated use weakens the high.
• Brain adjusts by reducing dopamine response.
• Sensitization develops
• In motivation and craving systems like the amygdala, VTA, and prefrontal cortex.
• These areas become more sensitive, making you crave more even if the drug feels weaker.
Key Takeaway:
• One drug can have multiple effects by acting on different brain regions. Cocaine weakens the reward (“tolerance”) but strengthens craving (“sensitization”) at the same time.